PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsPowdered cellulose
Powdered cellulose
Powdered cellulose is an unknown pharmaceutical. It is currently being investigated in clinical studies.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Cellulose sodium phosphate
Tradename
Company
Number
Date
Products
CALCIBINDMission PharmacalN-018757 DISCN1982-12-28
2 products
Hide discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
bio skin crystal bio-cellulose maskOTC monograph final2015-09-23
hankki ssog pre-biome shake (detox and diet shake)unapproved drug other2025-05-28
lacrisertNew Drug Application2024-07-25
limulus bio cellulose maskunapproved drug other2017-06-28
miracle of skinunapproved drug other2018-03-23
optase allegroC2002632024-12-17
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
1374 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Healthy volunteers/patients307325492
ObesityD009765EFO_0001073E66.9311382852
OverweightD050177E66.323313139
Diabetes mellitusD003920EFO_0000400E08-E13415621338
SyndromeD013577311451938
Type 2 diabetes mellitusD003924EFO_0001360E11412461237
InfectionsD007239EFO_0000544310531435
InflammationD007249MP_000184537122133
HypertensionD006973EFO_0000537I102451525
Prediabetic stateD011236EFO_1001121R73.032122024
Show 164 more
Indications Phases 2
Indications Phases 1
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
AffectD00033988
ExerciseD015444EFO_000048366
Psychological well-beingD00009286255
Surgical woundD00007283644
Psychological stressD01331544
Mental fatigueD00522244
AlopeciaD000505L6444
Healthy dietD00007200144
PostmenopauseD01769833
Pediatric obesityD06376633
Show 199 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common namePowdered cellulose
INN_
Description
Lacrisert (microcrystalline cellulose) is an insert placed in the eye to treat moderate to severe dry eyes. It also can be used to treat the following eye conditions: exposure keratitis, decreased corneal sensitivity and recurrent corneal erosions.
Classification
Small molecule
Drug class
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
Identifiers
PDB
CAS-ID
RxCUI
ChEMBL IDCHEMBL4297557
ChEBI ID
PubChem CID
DrugBank
UNII IDZY7ZTE7LFH (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
Revenue by drug
$
£
No data
Estimated US medical usage
Powdered cellulose
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
5,885 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use